Picture of Cerenome logo

CNSY — Cerenome News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Plus Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

* Plus Therapeutics Inc  PSTV.OQ  reported a quarterly
adjusted
loss of 75 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-2.10.  The mean expectation of three analysts
for the quarter was for a loss of $1.09 per share. Wall Street
expected results to range from $-1.46 to -72 cents per share.
    * Revenue rose 231.4% to $1.68 million from a year ago;
analysts
expected $1.69 million. 
    * Plus Therapeutics Inc's reported EPS for the quarter was a
loss
of 75 cents​.
    * The company reported a quarterly loss of $3.26 million.
    * Plus Therapeutics Inc shares had risen by 20.2% this
quarter and
gained 24.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 107%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Plus Therapeutics
Inc is $22.00 
This summary was machine generated from LSEG data May 15 at
09:04 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.09          -0.75          Beat
 Dec. 31 2023      -1.07          -0.84          Beat
 Sep. 30 2023      -1.12          -1.00          Beat
 Jun. 30 2023      -1.91          -0.59          Beat

Recent news on Cerenome

See all news